What are the most common co-occurring diagnoses for adolescents with substance use disorders? How are these co-occurring diagnoses different from an adult? Why is it important to know the difference between the two?"

Avenevoli, S., Swendsen, J., He, J. P., Burstein, M., & Merikangas, K. R. (2015). Major depression in the national comorbidity survey-adolescent supplement: Prevalence, correlates, and treatment. Journal of the American Academy of Child & Adolescent Psychiatry, 54(1), 37-44.

Grella, C. E., Hser, Y. I., Joshi, V., & Rounds-Bryant, J. (2001). Drug treatment outcomes for adolescents with comorbid mental and substance use disorders. Journal of Nervous and Mental Disease, 189(6), 384-392.

Haberstick, B. C., Lessem, J. M., Hopfer, C. J., Smolen, A., Ehringer, M. A., Timberlake, D., & Hewitt, J. K. (2016). Monoamine oxidase A (MAOA) and antisocial behaviors in the presence of childhood and adolescent maltreatment. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 171(6), 812-821.

Kingston, S., Smith, A., & Hurley, P. (2015). Substance use and addiction: Implications for intervention in the juvenile justice system. Child and Adolescent Psychiatric Clinics, 24(3), 563-579.

Lai, H. M. X., Cleary, M., Sitharthan, T., & Hunt, G. E. (2015). Prevalence of comorbid substance use, anxiety and mood disorders in epidemiological surveys, 1990-2014: A systematic review and meta-analysis. Drug and Alcohol Dependence, 154, 1-13.

Molina, B. S. G., Flory, K., Bukstein, O. G., & Greiner, A. R. (2019). Attention-deficit/hyperactivity disorder and substance abuse: What is the relationship? Child and Adolescent Psychiatric Clinics, 28(3), 299-305.